Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AIDS vaccine development in primate models.

× No keyword cloud information.

14 in total

1. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors: N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal: J Virol Date: 2000-01 Impact factor: 5.103

2. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.

Authors: B Rosenwirth; P ten Haaft; W M Bogers; I G Nieuwenhuis; H Niphuis; E M Kuhn; N Bischofberger; J L Heeney; K Uberla
Journal: J Virol Date: 2000-02 Impact factor: 5.103

3. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Authors: I Ourmanov; C R Brown; B Moss; M Carroll; L Wyatt; L Pletneva; S Goldstein; D Venzon; V M Hirsch
Journal: J Virol Date: 2000-03 Impact factor: 5.103

4. Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.

Authors: T Matano; M Kano; H Nakamura; A Takeda; Y Nagai
Journal: J Virol Date: 2001-12 Impact factor: 5.103

5. Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.

Authors: S Andersson; O Larsen; Z Da Silva; H Linder; H Norrgren; F Dias; R Thorstensson; P Aaby; G Biberfeld
Journal: Clin Exp Immunol Date: 2005-03 Impact factor: 4.330

6. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors: V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal: J Virol Date: 2002-06 Impact factor: 5.103

7. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.

Authors: Peter Silvera; Max W Richardson; Jack Greenhouse; Jake Yalley-Ogunro; Nigel Shaw; Jyotika Mirchandani; Kamel Khalili; Jean-Francois Zagury; Mark G Lewis; Jay Rappaport
Journal: J Virol Date: 2002-04 Impact factor: 5.103

8. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.

Authors: B R Gundlach; M G Lewis; S Sopper; T Schnell; J Sodroski; C Stahl-Hennig; K Uberla
Journal: J Virol Date: 2000-04 Impact factor: 5.103

9. Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines.

Authors: P Polacino; V Stallard; D C Montefiori; C R Brown; B A Richardson; W R Morton; R E Benveniste; S L Hu
Journal: J Virol Date: 1999-04 Impact factor: 5.103

10. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors: V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal: J Virol Date: 2002-10 Impact factor: 5.103